88455-08-7 Usage
Uses
Used in Pharmaceutical Industry:
(2S)-3-methyl-2-[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]buta noic acid is used as a key building block for the development of new pharmaceutical compounds. Its unique structure and functional properties make it a promising candidate for the design and synthesis of novel drugs with improved therapeutic effects.
Used in Biochemical Research:
(2S)-3-methyl-2-[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]buta noic acid is used as a research tool in biochemical studies. Its unique chemical structure allows scientists to investigate the role of beta-amino acids in the biosynthesis of peptides and proteins, as well as their contribution to the structural and functional diversity of biological molecules.
Used in Nutritional Supplements:
(2S)-3-methyl-2-[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]buta noic acid is used as an ingredient in nutritional supplements. Its role in the biosynthesis of peptides and proteins can support the maintenance of healthy bodily functions and contribute to overall well-being.
Used in Cosmetics Industry:
(2S)-3-methyl-2-[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]buta noic acid is used as an active ingredient in cosmetics. Its unique properties can contribute to the development of innovative skincare and beauty products with enhanced efficacy and benefits for the users.
Check Digit Verification of cas no
The CAS Registry Mumber 88455-08-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,8,4,5 and 5 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 88455-08:
(7*8)+(6*8)+(5*4)+(4*5)+(3*5)+(2*0)+(1*8)=167
167 % 10 = 7
So 88455-08-7 is a valid CAS Registry Number.
InChI:InChI=1/C11H23NO7/c1-5(2)8(11(18)19)12-3-6(14)9(16)10(17)7(15)4-13/h5-10,12-17H,3-4H2,1-2H3,(H,18,19)/t6-,7+,8-,9+,10+/m0/s1
88455-08-7Relevant academic research and scientific papers
SYNTHETIC ROUTES TO N-(1-DEOXY-D-FRUCTOS-1-YL)AMINO ACIDS BY WAY OF REDUCTIVE AMINATION OF HEXOS-2-ULOSES
Walton, Donald J.,McPherson, John D.
, p. 123 - 130 (2007/10/02)
There are described two routes to the synthesis of N-(1-deoxy-D-fructos-1-yl) derivatives of L-valine, L-leucine, L-methionine, L-phenylalanine, and 6-aminohexanoic acid.One route involved reductive amination of D-arabino-hexos-2-ulose in the presence of
SYNTHESIS OF N-(1-DEOXYHEXITOL-1-YL)AMINO ACIDS, REFERENCE COMPOUNDS FOR THE NONENZYMIC GLYCOSYLATION OF PROTEINS
Walton, Donald J.,Ison, Edward R.,Szarek, Walter A.
, p. 37 - 50 (2007/10/02)
The N-(1-deoxy-D-mannitol-1-yl) and N-(1-deoxy-D-glucitol-1-yl) derivatives of L-valine, L-alanine, L-threonine, and L-leucine were prepared by reductive amination of D-mannose and D-glucose with appropriate amino acids, in the presence of sodium cyanoborohydride.Nε-(1-deoxy-D-mannitol-1-yl)- and Nε-(1-deoxy-D-glucitol-1-yl)-L-lysine were prepared by similar reactions of hexoses with Nα-tert-butoxycarbonyl and Nα-benzyloxycarbonyl-L-lysine, followed by removal of the protecting groups.The structures were confirmed by (1)H-n.m.r. spectroscopy, which showed that each compound was completely free of its C-2 epimer.The synthetic compounds may be used as reference compounds for the identification of N-(1-deoxyhexitol-1-yl)amino acids formed when N-(1-deoxy-D-fructose-1-yl) groups of nonenzymically glycosylated proteins, of the hemoglobin A1c type, are reduced with sodium borohydride, and the protein is subjected to acid-catalyzed hydrolysis.
